Camposomes™
Aphios
is developing a nanosomal formulation of camptothecin, a potent
and exciting anti-cancer agent. Water soluble derivatives
of camptothecin, a unique topoisomerase 1 inhibitor, have
recently been approved by the FDA for use in colorectal cancer.
These derivatives may not be as stable or as effective
as neat camptothecin derived from the Chinese tree, Camptotheca
acuminata. To date, the National Cancer Institute
of the NIH has conducted in vivo studies on Aphios'
Camposomes™ product against lymphomas in nude mice with
positive results.
For
more information, contact Aphios.
Home
l Company | Infectious
Diseases | Oncology | Nutraceuticals
| Product Pipeline | Purchase
Products | Technology Platforms
| Equipment |Patents
| Press
Releases | Contact Aphios
©1999-
2007 Aphios® Corporation
All rights reserved
|